Source
European Journal of Endocrinology .
Takeaway
Systematic review shows clear benefits of metformin on anthropometric and metabolic outcomes compared with placebo in women with polycystic ovary syndrome (PCOS).
Metformin has mild gastrointestinal side effects that are generally dose-dependent and short-term.
Use of metformin in PCOS is evidence-based but off-label. ...